1 asset in Small Intestine Disorder
Therapeutic assets addressing Small Intestine Disorder, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Rifaximin Small Intestine Disorder | Wake Forest University Health Sciences | P2/3 | B (57) |